<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02025426</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00032812</org_study_id>
    <nct_id>NCT02025426</nct_id>
  </id_info>
  <brief_title>Phenylephrine Versus Ephedrine in Pre-eclampsia</brief_title>
  <official_title>Impact of Vasopressor Administration on Maternal and Neonatal Outcomes in Women With Pre-eclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phenylephrine administration is associated with reductions in CO and SctO2 compared with&#xD;
      ephedrine when used for blood pressure management in women with pre-eclampsia undergoing&#xD;
      cesarean delivery under spinal anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Significant challenges recruiting a difficult patient population with most surgeries occurring&#xD;
    out of hours&#xD;
  </why_stopped>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">July 8, 2016</completion_date>
  <primary_completion_date type="Actual">July 8, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral Tissue Oxygen Saturation</measure>
    <time_frame>Intraoperative from spinal placement till 10 min after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac Output</measure>
    <time_frame>Intraoperative from spinal placement till 10 min after delivery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Neonatal Umbilical Cord Gases, pCO2</measure>
    <time_frame>Within 5 minutes after delivery</time_frame>
    <description>Partial pressure of carbon dioxide (pCO2) is the measure of carbon dioxide within arterial blood flowing through the umbilical cord.</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal Umbilical Cord Gases, pH</measure>
    <time_frame>Within 5 minutes after delivery</time_frame>
    <description>Used to assess acid-base balance. pH ranges from 0 to 14 and a pH of 7.40 is considered standard (normal) conditions.</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal Umbilical Cord Gases, BE</measure>
    <time_frame>Within 5 minutes after delivery</time_frame>
    <description>The amount of strong acid (in mmol/L) that needs to be added in vitro to 1 liter of fully oxygenated blood in order to return the sample to standard (normal) conditions (pH 7.40, pCO2 40 mmHg and temperature 37 °C.)</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants With Intraoperative Hypotension</measure>
    <time_frame>Intraoperatively from spinal placement till 10 minutes after delivery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants With Intraoperative Nausea</measure>
    <time_frame>Intraoperatively from time of spinal placement until end of surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants With Intraoperative Vomiting</measure>
    <time_frame>Intraoperatively from time of spinal placement until end of surgery</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Pre-eclampsia</condition>
  <arm_group>
    <arm_group_label>Phenylephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phenylephrine for maintaining blood pressure within 10 % of baseline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ephedrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ephedrine for maintaining blood pressure within 10 % of baseline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <arm_group_label>Phenylephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ephedrine</intervention_name>
    <arm_group_label>Ephedrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Age ≥18 yrs&#xD;
&#xD;
          -  Pre-eclampsia (mild, or severe)&#xD;
&#xD;
          -  Non-laboring women&#xD;
&#xD;
          -  CD under spinal anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Height &lt; 5'0&quot;&#xD;
&#xD;
          -  Allergy to phenylephrine or ephedrine, or any other standardized medication&#xD;
&#xD;
          -  Severe Cardiac disease in pregnancy with marked functional limitations (NYHA Class III&#xD;
             and IV)&#xD;
&#xD;
          -  Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants&#xD;
&#xD;
          -  History of recent amphetamine or cocaine use.&#xD;
&#xD;
          -  Subject enrollment in another study involving a study medication within 30 days of CD&#xD;
&#xD;
          -  Any other physical or psychiatric condition which may impair their ability to&#xD;
             cooperate with study data collection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashraf S Habib, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 26, 2013</study_first_submitted>
  <study_first_submitted_qc>December 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2014</study_first_posted>
  <results_first_submitted>September 18, 2020</results_first_submitted>
  <results_first_submitted_qc>September 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 14, 2020</results_first_posted>
  <disposition_first_submitted>January 7, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>January 7, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">January 10, 2020</disposition_first_posted>
  <last_update_submitted>September 18, 2020</last_update_submitted>
  <last_update_submitted_qc>September 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cesarean delivery</keyword>
  <keyword>Spinal Anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Ephedrine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Phenylephrine</title>
          <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
        </group>
        <group group_id="P2">
          <title>Ephedrine</title>
          <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Phenylephrine</title>
          <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
        </group>
        <group group_id="B2">
          <title>Ephedrine</title>
          <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.89" spread="8.72"/>
                    <measurement group_id="B2" value="39.25" spread="10.14"/>
                    <measurement group_id="B3" value="32.77" spread="9.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107.76" spread="29.62"/>
                    <measurement group_id="B2" value="117.35" spread="27.26"/>
                    <measurement group_id="B3" value="110.71" spread="28.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (Body Mass Index)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.53" spread="11.58"/>
                    <measurement group_id="B2" value="44.55" spread="12.85"/>
                    <measurement group_id="B3" value="41.77" spread="11.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163.22" spread="4.94"/>
                    <measurement group_id="B2" value="163.47" spread="6.47"/>
                    <measurement group_id="B3" value="163.30" spread="5.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational Age</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.67" spread="4.42"/>
                    <measurement group_id="B2" value="35.25" spread="3.59"/>
                    <measurement group_id="B3" value="33.46" spread="4.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gravida</title>
          <description>The total number of confirmed pregnancies that a woman has had, regardless of the outcome.</description>
          <units>pregnancies</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.00" spread="1.85"/>
                    <measurement group_id="B2" value="3.25" spread="1.26"/>
                    <measurement group_id="B3" value="3.08" spread="1.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Para</title>
          <description>The number of births that a woman has had after 20 weeks gestation.</description>
          <units>births</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.25" spread="1.04"/>
                    <measurement group_id="B2" value="1.50" spread="1.29"/>
                    <measurement group_id="B3" value="1.33" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cerebral Tissue Oxygen Saturation</title>
        <time_frame>Intraoperative from spinal placement till 10 min after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Tissue Oxygen Saturation</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.08" spread="29.32"/>
                    <measurement group_id="O2" value="19.10" spread="7.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.547</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Output</title>
        <time_frame>Intraoperative from spinal placement till 10 min after delivery</time_frame>
        <population>Data for cardiac output from Physioflow worksheets was not available for two participants in the Phenylephrine group and all four participants in the Ephedrine group.</population>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Output</title>
          <population>Data for cardiac output from Physioflow worksheets was not available for two participants in the Phenylephrine group and all four participants in the Ephedrine group.</population>
          <units>mL/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.19" spread="4.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neonatal Umbilical Cord Gases, pCO2</title>
        <description>Partial pressure of carbon dioxide (pCO2) is the measure of carbon dioxide within arterial blood flowing through the umbilical cord.</description>
        <time_frame>Within 5 minutes after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Umbilical Cord Gases, pCO2</title>
          <description>Partial pressure of carbon dioxide (pCO2) is the measure of carbon dioxide within arterial blood flowing through the umbilical cord.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.71" spread="11.80"/>
                    <measurement group_id="O2" value="55.93" spread="12.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.925</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neonatal Umbilical Cord Gases, pH</title>
        <description>Used to assess acid-base balance. pH ranges from 0 to 14 and a pH of 7.40 is considered standard (normal) conditions.</description>
        <time_frame>Within 5 minutes after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Umbilical Cord Gases, pH</title>
          <description>Used to assess acid-base balance. pH ranges from 0 to 14 and a pH of 7.40 is considered standard (normal) conditions.</description>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.24" spread="0.07"/>
                    <measurement group_id="O2" value="7.19" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.498</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neonatal Umbilical Cord Gases, BE</title>
        <description>The amount of strong acid (in mmol/L) that needs to be added in vitro to 1 liter of fully oxygenated blood in order to return the sample to standard (normal) conditions (pH 7.40, pCO2 40 mmHg and temperature 37 °C.)</description>
        <time_frame>Within 5 minutes after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Umbilical Cord Gases, BE</title>
          <description>The amount of strong acid (in mmol/L) that needs to be added in vitro to 1 liter of fully oxygenated blood in order to return the sample to standard (normal) conditions (pH 7.40, pCO2 40 mmHg and temperature 37 °C.)</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.83" spread="2.47"/>
                    <measurement group_id="O2" value="-8.23" spread="6.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.201</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Intraoperative Hypotension</title>
        <time_frame>Intraoperatively from spinal placement till 10 minutes after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Intraoperative Hypotension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&gt;0.999</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Intraoperative Nausea</title>
        <time_frame>Intraoperatively from time of spinal placement until end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Intraoperative Nausea</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.962</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Intraoperative Vomiting</title>
        <time_frame>Intraoperatively from time of spinal placement until end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine</title>
            <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
          </group>
          <group group_id="O2">
            <title>Ephedrine</title>
            <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Intraoperative Vomiting</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&gt;0.999</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From admission to discharge (no more than a few days).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Phenylephrine</title>
          <description>Phenylephrine for maintaining blood pressure within 10 % of baseline&#xD;
Phenylephrine</description>
        </group>
        <group group_id="E2">
          <title>Ephedrine</title>
          <description>Ephedrine for maintaining blood pressure within 10 % of baseline&#xD;
Ephedrine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ashraf Habib</name_or_title>
      <organization>Duke University, School of Medicine, Department of Anesthesiology</organization>
      <phone>(919) 681-4544</phone>
      <email>ashraf.habib@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

